Howard Kim

About the Author Howard Kim


Adobe (ADBE) Has a New Rating from Wedbush

In a report released yesterday, Jennifer Redding from Wedbush initiated coverage with a Hold rating on Adobe (NASDAQ: ADBE) and a price target …

Maxim Group Maintains Their Buy Rating on Anavex Life Sciences (AVXL)

In a report released today, Caroline Palomeque from Maxim Group maintained a Buy rating on Anavex Life Sciences (NASDAQ: AVXL), with a price …

Roth Capital Maintains a Buy Rating on Arqule (ARQL)

Roth Capital analyst Jotin Marango maintained a Buy rating on Arqule (NASDAQ: ARQL) today and set a price target of $7. The company’s …

Intuitive Surgical (ISRG) Receives a Buy from Merrill Lynch

Merrill Lynch analyst Bob Hopkins reiterated a Buy rating on Intuitive Surgical (NASDAQ: ISRG) today and set a price target of $600. The …

Bank OZK (OZK) Gets a Hold Rating from Stephens

Stephens analyst Matt Olney assigned a Hold rating to Bank OZK (NASDAQ: OZK) yesterday and set a price target of $48. The company’s …

Ameris Bancorp (ABCB) Receives a Buy from Stephens

In a report released today, Tyler Stafford from Stephens maintained a Buy rating on Ameris Bancorp (NASDAQ: ABCB), with a price target of …

Exponent (EXPO) Gets a Buy Rating from Cantor Fitzgerald

In a report released today, Joseph Foresi from Cantor Fitzgerald maintained a Buy rating on Exponent (NASDAQ: EXPO), with a price target of …

Sarepta Therapeutics (SRPT) Received its Third Buy in a Row

After Needham and Barclays gave Sarepta Therapeutics (NASDAQ: SRPT) a Buy rating last month, the company received another Buy, this time from H.C.